ATE209256T1 - Schnelle krebs-diagnose - Google Patents

Schnelle krebs-diagnose

Info

Publication number
ATE209256T1
ATE209256T1 AT98912475T AT98912475T ATE209256T1 AT E209256 T1 ATE209256 T1 AT E209256T1 AT 98912475 T AT98912475 T AT 98912475T AT 98912475 T AT98912475 T AT 98912475T AT E209256 T1 ATE209256 T1 AT E209256T1
Authority
AT
Austria
Prior art keywords
cancer diagnosis
cancer
quick
quick cancer
diagnosis
Prior art date
Application number
AT98912475T
Other languages
English (en)
Inventor
Ioan Puscas
Iuliana Carmen Puscas
Marcela Coltau
Gabriela Domuta
Michael Baican
Original Assignee
Ioan Puscas
Iuliana Carmen Puscas
Marcela Coltau
Gabriela Domuta
Michael Baican
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioan Puscas, Iuliana Carmen Puscas, Marcela Coltau, Gabriela Domuta, Michael Baican filed Critical Ioan Puscas
Application granted granted Critical
Publication of ATE209256T1 publication Critical patent/ATE209256T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98912475T 1997-03-17 1998-03-13 Schnelle krebs-diagnose ATE209256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RO97-00502A RO114835B1 (ro) 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor
PCT/EP1998/001465 WO1998041649A2 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis

Publications (1)

Publication Number Publication Date
ATE209256T1 true ATE209256T1 (de) 2001-12-15

Family

ID=20104983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912475T ATE209256T1 (de) 1997-03-17 1998-03-13 Schnelle krebs-diagnose

Country Status (13)

Country Link
US (1) US6326161B1 (de)
EP (1) EP0972072B1 (de)
JP (1) JP2001524815A (de)
CN (1) CN1256713A (de)
AT (1) ATE209256T1 (de)
AU (1) AU738843B2 (de)
BR (1) BR9808373A (de)
CA (1) CA2284632A1 (de)
DE (1) DE69803279D1 (de)
EA (1) EA003185B1 (de)
NZ (1) NZ337850A (de)
RO (1) RO114835B1 (de)
WO (1) WO1998041649A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100135980A1 (en) * 2000-10-16 2010-06-03 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
US7329495B2 (en) * 2004-06-09 2008-02-12 Board Of Regents, The University Of Texas System Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
ES2587994T3 (es) 2010-01-21 2016-10-28 The Research Foundation Of State University Of New York Método de diagnóstico de la enfermedad de Sjögren
GB201009798D0 (en) * 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US20120231479A1 (en) 2010-09-09 2012-09-13 Robert Puskas Combination methods of diagnosing cancer in a patient
EP2894477A4 (de) * 2012-09-05 2016-07-20 Wako Pure Chem Ind Ltd Verfahren zum nachweis von brustkrebs
CN104630380B (zh) * 2015-03-06 2016-08-24 河北医科大学第四医院 碳酸酐酶iv在制备肺腺癌诊断制剂中的应用
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
CN105785004B (zh) * 2016-03-31 2017-11-10 中国医学科学院北京协和医院 细胞分裂周期相关蛋白2在胰腺癌诊断或预后中的用途
CN108287239B (zh) * 2017-12-08 2020-07-17 福建医科大学附属第一医院 血清ca2蛋白在制备肝癌诊断或预后评估试剂盒中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma

Also Published As

Publication number Publication date
NZ337850A (en) 2001-07-27
WO1998041649A3 (en) 1998-12-23
AU6729898A (en) 1998-10-12
CA2284632A1 (en) 1998-09-24
EP0972072A2 (de) 2000-01-19
RO114835B1 (ro) 1999-07-30
CN1256713A (zh) 2000-06-14
JP2001524815A (ja) 2001-12-04
DE69803279D1 (de) 2002-02-21
EP0972072B1 (de) 2001-11-21
AU738843B2 (en) 2001-09-27
US6326161B1 (en) 2001-12-04
EA003185B1 (ru) 2003-02-27
EA199900775A1 (ru) 2000-06-26
WO1998041649A2 (en) 1998-09-24
BR9808373A (pt) 2000-05-23

Similar Documents

Publication Publication Date Title
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
BR9807734A (pt) Composto para imunodiagnose de câncer de próstata e métodos para o uso dos memos
DE69842134D1 (de) Elektronische verfahren und vorrichtung zum nachweis von analyten
ATE209256T1 (de) Schnelle krebs-diagnose
DE3675717D1 (de) Verfahren zur sulphatierung von glykosaminoglykanen, daraus hergestellte glykosaminoglykane und ihre biologischen verwendungen.
ATE433498T1 (de) Detektion von neoplasien durch speichelanalyse
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
NO985150D0 (no) Antigenbindende fragment som sµrlig sporer kreftceller, nukleoid som koder nevnte fragment, samt bruk av dette ved forebygging og pÕvisning av kreft
DE69737788D1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
CA2164498A1 (en) Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
DK130387A (da) Transglutaminase inhibitorer
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
ATE17262T1 (de) Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma.
DE69001972T2 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
EP1045027A4 (de) Neues gen mit einem revers-transkriptase-motiv
BR9609026A (pt) Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
ES2176523T3 (es) Procedimiento para la deteccion de la enfermedad de alzheimer.
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
ATE135468T1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
DE3889232D1 (de) Verfahren zum quantitativen Nachweis von Sauerstoff.
DE69024703T2 (de) Verfahren zum Nachweis von Krankheiten
Larralde et al. Porphyrin content of the cysticercus of Taenia solium
ATE5254T1 (de) Tripeptidderivate und verfahren zur bestimmung von enzymen mittels derselben.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties